MARK FERGESON: Open Payments
NPI 1497170526 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 33 payments from 6 companies in 2025. Trend: 2023 $42 · 2024 $581 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $228 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $186 |
| PFIZER INC. | 4 | $174 |
| Janssen Pharmaceuticals, Inc | 2 | $160 |
| Amgen Inc. | 1 | $133 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
Products named: CAPLYTA, NURTEC ODT, SPRAVATO, QULIPTA, REPATHA, UBRELVY, NP Thyroid 60, VRAYLAR.
Industry payments across OK — which companies pay providers there.
